Phosphorylation of 4E-BP1 in the Mammalian Brain Is Not Altered by LRRK2 Expression or Pathogenic Mutations
Alžbeta Trančíková(École Polytechnique Fédérale de Lausanne), Darren J. Moore(École Polytechnique Fédérale de Lausanne)
Cited by 42
Related Papers
GTPase Activity and Neuronal Toxicity of Parkinson's Disease–Associated LRRK2 Is Regulated by ArfGAP1
|PLoS Genetics|2012|138
Conditional transgenic mice expressing C-terminally truncated human α-synuclein (αSyn119) exhibit reduced striatal dopamine without loss of nigrostriatal pathway dopaminergic neurons
|Molecular Neurodegeneration|2009|94
Parkin mediates the ubiquitination of VPS35 and modulates retromer-dependent endosomal sorting
|Human Molecular Genetics|2018|76
Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity
|Proceedings of the National Academy of Sciences|2020|69
Parkinson’s disease-associated LRRK2 risk variant, G2385R, enhances Rab substrate phosphorylation and impairs neuronal integrity
|bioRxiv (Cold Spring Harbor Laboratory)|2026|0